Smith+Nephew CARTIHEAL AGILI-C trial shows higher KOOS scores at 5 years

• Smith+Nephew reported 5-year results from a multicenter randomized controlled trial of its CARTIHEAL AGILI-C cartilage repair implant, with findings already published in American Journal of Sports Medicine.
• Trial data showed the implant delivered better pain relief and quality-of-life outcomes than surgical standard of care over the study period.
• Patients also posted stronger functional improvements in daily activities and sport-related tasks versus standard care.
• Outcomes were comparable in patients with osteoarthritis and those without, supporting use across a broader treatment population.
• Smith+Nephew flagged a Category I CPT code for procedures using the implant that takes effect Jan. 1, 2027, a step that could support future US adoption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Smith & Nephew plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604210800OMX_____CNEWS_EN_GNW1001176855_en) on April 21, 2026, and is solely responsible for the information contained therein.